Paula Cramer, Julia v. Tresckow, Sandra Robrecht, Jasmin Bahlo, Moritz Fürstenau, Petra Langerbeins, Natali Pflug, Othman Al-Sawaf, Werner J. Heinz, Ursula Vehling-Kaiser, Jan Dürig, Eugen Tausch, Manfred Hensel, Stephanie Sasse, Anna-Maria Fink, Kirsten Fischer, Karl-Anton Kreuzer, Sebastian Böttcher, Matthias Ritgen, Michael Kneba, Clemens-Martin Wendtner, Stephan Stilgenbauer, Barbara Eichhorst, and Michael Hallek. 2021. “Bendamustine, Followed by Ofatumumab and Ibrutinib in Chronic Lymphocytic Leukemia (CLL2-BIO): Primary Endpoint Analysis of a Multicenter, Open-Label Phase-II Trial”. Haematologica 106 (2). Pavia, Italy, 543-54. https://doi.org/10.3324/haematol.2019.223693.